Pharma & Healthcare

Global Endothelin Receptor Antagonist Market Research Report 2025

The global market for Endothelin Receptor Antagonist was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Endothelin Receptor Antagonist is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Endothelin Receptor Antagonist is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Endothelin Receptor Antagonist in Hospital Pharmacy is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Endothelin Receptor Antagonist include Gilead Sciences Inc., Glaxosmithkline Inc., Sun Pharmaceutical Industries, Inc., Mylan Pharmaceuticals Inc., Actavis Pharma, Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Endothelin Receptor Antagonist, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Endothelin Receptor Antagonist.
The Endothelin Receptor Antagonist market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Endothelin Receptor Antagonist market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Endothelin Receptor Antagonist companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Gilead Sciences Inc.
Glaxosmithkline Inc.
Sun Pharmaceutical Industries, Inc.
Mylan Pharmaceuticals Inc.
Actavis Pharma, Inc.
Segment by Type
Ambrisentan
Bosentan
Macitentan
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Mail Order Pharmacy
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Endothelin Receptor Antagonist company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Endothelin Receptor Antagonist Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Ambrisentan
1.2.3 Bosentan
1.2.4 Macitentan
1.3 Market by Application
1.3.1 Global Endothelin Receptor Antagonist Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Mail Order Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Endothelin Receptor Antagonist Market Perspective (2020-2031)
2.2 Global Endothelin Receptor Antagonist Growth Trends by Region
2.2.1 Global Endothelin Receptor Antagonist Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Endothelin Receptor Antagonist Historic Market Size by Region (2020-2025)
2.2.3 Endothelin Receptor Antagonist Forecasted Market Size by Region (2026-2031)
2.3 Endothelin Receptor Antagonist Market Dynamics
2.3.1 Endothelin Receptor Antagonist Industry Trends
2.3.2 Endothelin Receptor Antagonist Market Drivers
2.3.3 Endothelin Receptor Antagonist Market Challenges
2.3.4 Endothelin Receptor Antagonist Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Endothelin Receptor Antagonist Players by Revenue
3.1.1 Global Top Endothelin Receptor Antagonist Players by Revenue (2020-2025)
3.1.2 Global Endothelin Receptor Antagonist Revenue Market Share by Players (2020-2025)
3.2 Global Endothelin Receptor Antagonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Endothelin Receptor Antagonist Revenue
3.4 Global Endothelin Receptor Antagonist Market Concentration Ratio
3.4.1 Global Endothelin Receptor Antagonist Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Endothelin Receptor Antagonist Revenue in 2024
3.5 Global Key Players of Endothelin Receptor Antagonist Head office and Area Served
3.6 Global Key Players of Endothelin Receptor Antagonist, Product and Application
3.7 Global Key Players of Endothelin Receptor Antagonist, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Endothelin Receptor Antagonist Breakdown Data by Type
4.1 Global Endothelin Receptor Antagonist Historic Market Size by Type (2020-2025)
4.2 Global Endothelin Receptor Antagonist Forecasted Market Size by Type (2026-2031)
5 Endothelin Receptor Antagonist Breakdown Data by Application
5.1 Global Endothelin Receptor Antagonist Historic Market Size by Application (2020-2025)
5.2 Global Endothelin Receptor Antagonist Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Endothelin Receptor Antagonist Market Size (2020-2031)
6.2 North America Endothelin Receptor Antagonist Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Endothelin Receptor Antagonist Market Size by Country (2020-2025)
6.4 North America Endothelin Receptor Antagonist Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Endothelin Receptor Antagonist Market Size (2020-2031)
7.2 Europe Endothelin Receptor Antagonist Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Endothelin Receptor Antagonist Market Size by Country (2020-2025)
7.4 Europe Endothelin Receptor Antagonist Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Endothelin Receptor Antagonist Market Size (2020-2031)
8.2 Asia-Pacific Endothelin Receptor Antagonist Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Endothelin Receptor Antagonist Market Size by Region (2020-2025)
8.4 Asia-Pacific Endothelin Receptor Antagonist Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Endothelin Receptor Antagonist Market Size (2020-2031)
9.2 Latin America Endothelin Receptor Antagonist Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Endothelin Receptor Antagonist Market Size by Country (2020-2025)
9.4 Latin America Endothelin Receptor Antagonist Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Endothelin Receptor Antagonist Market Size (2020-2031)
10.2 Middle East & Africa Endothelin Receptor Antagonist Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Endothelin Receptor Antagonist Market Size by Country (2020-2025)
10.4 Middle East & Africa Endothelin Receptor Antagonist Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Gilead Sciences Inc.
11.1.1 Gilead Sciences Inc. Company Details
11.1.2 Gilead Sciences Inc. Business Overview
11.1.3 Gilead Sciences Inc. Endothelin Receptor Antagonist Introduction
11.1.4 Gilead Sciences Inc. Revenue in Endothelin Receptor Antagonist Business (2020-2025)
11.1.5 Gilead Sciences Inc. Recent Development
11.2 Glaxosmithkline Inc.
11.2.1 Glaxosmithkline Inc. Company Details
11.2.2 Glaxosmithkline Inc. Business Overview
11.2.3 Glaxosmithkline Inc. Endothelin Receptor Antagonist Introduction
11.2.4 Glaxosmithkline Inc. Revenue in Endothelin Receptor Antagonist Business (2020-2025)
11.2.5 Glaxosmithkline Inc. Recent Development
11.3 Sun Pharmaceutical Industries, Inc.
11.3.1 Sun Pharmaceutical Industries, Inc. Company Details
11.3.2 Sun Pharmaceutical Industries, Inc. Business Overview
11.3.3 Sun Pharmaceutical Industries, Inc. Endothelin Receptor Antagonist Introduction
11.3.4 Sun Pharmaceutical Industries, Inc. Revenue in Endothelin Receptor Antagonist Business (2020-2025)
11.3.5 Sun Pharmaceutical Industries, Inc. Recent Development
11.4 Mylan Pharmaceuticals Inc.
11.4.1 Mylan Pharmaceuticals Inc. Company Details
11.4.2 Mylan Pharmaceuticals Inc. Business Overview
11.4.3 Mylan Pharmaceuticals Inc. Endothelin Receptor Antagonist Introduction
11.4.4 Mylan Pharmaceuticals Inc. Revenue in Endothelin Receptor Antagonist Business (2020-2025)
11.4.5 Mylan Pharmaceuticals Inc. Recent Development
11.5 Actavis Pharma, Inc.
11.5.1 Actavis Pharma, Inc. Company Details
11.5.2 Actavis Pharma, Inc. Business Overview
11.5.3 Actavis Pharma, Inc. Endothelin Receptor Antagonist Introduction
11.5.4 Actavis Pharma, Inc. Revenue in Endothelin Receptor Antagonist Business (2020-2025)
11.5.5 Actavis Pharma, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Endothelin Receptor Antagonist Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Ambrisentan
Table 3. Key Players of Bosentan
Table 4. Key Players of Macitentan
Table 5. Global Endothelin Receptor Antagonist Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Endothelin Receptor Antagonist Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Endothelin Receptor Antagonist Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Endothelin Receptor Antagonist Market Share by Region (2020-2025)
Table 9. Global Endothelin Receptor Antagonist Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Endothelin Receptor Antagonist Market Share by Region (2026-2031)
Table 11. Endothelin Receptor Antagonist Market Trends
Table 12. Endothelin Receptor Antagonist Market Drivers
Table 13. Endothelin Receptor Antagonist Market Challenges
Table 14. Endothelin Receptor Antagonist Market Restraints
Table 15. Global Endothelin Receptor Antagonist Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Endothelin Receptor Antagonist Market Share by Players (2020-2025)
Table 17. Global Top Endothelin Receptor Antagonist Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endothelin Receptor Antagonist as of 2024)
Table 18. Ranking of Global Top Endothelin Receptor Antagonist Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Endothelin Receptor Antagonist Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Endothelin Receptor Antagonist, Headquarters and Area Served
Table 21. Global Key Players of Endothelin Receptor Antagonist, Product and Application
Table 22. Global Key Players of Endothelin Receptor Antagonist, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Endothelin Receptor Antagonist Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Endothelin Receptor Antagonist Revenue Market Share by Type (2020-2025)
Table 26. Global Endothelin Receptor Antagonist Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Endothelin Receptor Antagonist Revenue Market Share by Type (2026-2031)
Table 28. Global Endothelin Receptor Antagonist Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Endothelin Receptor Antagonist Revenue Market Share by Application (2020-2025)
Table 30. Global Endothelin Receptor Antagonist Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Endothelin Receptor Antagonist Revenue Market Share by Application (2026-2031)
Table 32. North America Endothelin Receptor Antagonist Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Endothelin Receptor Antagonist Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Endothelin Receptor Antagonist Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Endothelin Receptor Antagonist Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Endothelin Receptor Antagonist Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Endothelin Receptor Antagonist Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Endothelin Receptor Antagonist Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Endothelin Receptor Antagonist Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Endothelin Receptor Antagonist Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Endothelin Receptor Antagonist Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Endothelin Receptor Antagonist Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Endothelin Receptor Antagonist Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Endothelin Receptor Antagonist Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Endothelin Receptor Antagonist Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Endothelin Receptor Antagonist Market Size by Country (2026-2031) & (US$ Million)
Table 47. Gilead Sciences Inc. Company Details
Table 48. Gilead Sciences Inc. Business Overview
Table 49. Gilead Sciences Inc. Endothelin Receptor Antagonist Product
Table 50. Gilead Sciences Inc. Revenue in Endothelin Receptor Antagonist Business (2020-2025) & (US$ Million)
Table 51. Gilead Sciences Inc. Recent Development
Table 52. Glaxosmithkline Inc. Company Details
Table 53. Glaxosmithkline Inc. Business Overview
Table 54. Glaxosmithkline Inc. Endothelin Receptor Antagonist Product
Table 55. Glaxosmithkline Inc. Revenue in Endothelin Receptor Antagonist Business (2020-2025) & (US$ Million)
Table 56. Glaxosmithkline Inc. Recent Development
Table 57. Sun Pharmaceutical Industries, Inc. Company Details
Table 58. Sun Pharmaceutical Industries, Inc. Business Overview
Table 59. Sun Pharmaceutical Industries, Inc. Endothelin Receptor Antagonist Product
Table 60. Sun Pharmaceutical Industries, Inc. Revenue in Endothelin Receptor Antagonist Business (2020-2025) & (US$ Million)
Table 61. Sun Pharmaceutical Industries, Inc. Recent Development
Table 62. Mylan Pharmaceuticals Inc. Company Details
Table 63. Mylan Pharmaceuticals Inc. Business Overview
Table 64. Mylan Pharmaceuticals Inc. Endothelin Receptor Antagonist Product
Table 65. Mylan Pharmaceuticals Inc. Revenue in Endothelin Receptor Antagonist Business (2020-2025) & (US$ Million)
Table 66. Mylan Pharmaceuticals Inc. Recent Development
Table 67. Actavis Pharma, Inc. Company Details
Table 68. Actavis Pharma, Inc. Business Overview
Table 69. Actavis Pharma, Inc. Endothelin Receptor Antagonist Product
Table 70. Actavis Pharma, Inc. Revenue in Endothelin Receptor Antagonist Business (2020-2025) & (US$ Million)
Table 71. Actavis Pharma, Inc. Recent Development
Table 72. Research Programs/Design for This Report
Table 73. Key Data Information from Secondary Sources
Table 74. Key Data Information from Primary Sources
Table 75. Authors List of This Report


List of Figures
Figure 1. Endothelin Receptor Antagonist Picture
Figure 2. Global Endothelin Receptor Antagonist Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Endothelin Receptor Antagonist Market Share by Type: 2024 VS 2031
Figure 4. Ambrisentan Features
Figure 5. Bosentan Features
Figure 6. Macitentan Features
Figure 7. Global Endothelin Receptor Antagonist Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Endothelin Receptor Antagonist Market Share by Application: 2024 VS 2031
Figure 9. Hospital Pharmacy Case Studies
Figure 10. Retail Pharmacy Case Studies
Figure 11. Mail Order Pharmacy Case Studies
Figure 12. Endothelin Receptor Antagonist Report Years Considered
Figure 13. Global Endothelin Receptor Antagonist Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Endothelin Receptor Antagonist Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Endothelin Receptor Antagonist Market Share by Region: 2024 VS 2031
Figure 16. Global Endothelin Receptor Antagonist Market Share by Players in 2024
Figure 17. Global Top Endothelin Receptor Antagonist Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endothelin Receptor Antagonist as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Endothelin Receptor Antagonist Revenue in 2024
Figure 19. North America Endothelin Receptor Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Endothelin Receptor Antagonist Market Share by Country (2020-2031)
Figure 21. United States Endothelin Receptor Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Endothelin Receptor Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Endothelin Receptor Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Endothelin Receptor Antagonist Market Share by Country (2020-2031)
Figure 25. Germany Endothelin Receptor Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Endothelin Receptor Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Endothelin Receptor Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Endothelin Receptor Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Endothelin Receptor Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Endothelin Receptor Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Endothelin Receptor Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Endothelin Receptor Antagonist Market Share by Region (2020-2031)
Figure 33. China Endothelin Receptor Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Endothelin Receptor Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Endothelin Receptor Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Endothelin Receptor Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Endothelin Receptor Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Endothelin Receptor Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Endothelin Receptor Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Endothelin Receptor Antagonist Market Share by Country (2020-2031)
Figure 41. Mexico Endothelin Receptor Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Endothelin Receptor Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Endothelin Receptor Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Endothelin Receptor Antagonist Market Share by Country (2020-2031)
Figure 45. Turkey Endothelin Receptor Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Endothelin Receptor Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Endothelin Receptor Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Gilead Sciences Inc. Revenue Growth Rate in Endothelin Receptor Antagonist Business (2020-2025)
Figure 49. Glaxosmithkline Inc. Revenue Growth Rate in Endothelin Receptor Antagonist Business (2020-2025)
Figure 50. Sun Pharmaceutical Industries, Inc. Revenue Growth Rate in Endothelin Receptor Antagonist Business (2020-2025)
Figure 51. Mylan Pharmaceuticals Inc. Revenue Growth Rate in Endothelin Receptor Antagonist Business (2020-2025)
Figure 52. Actavis Pharma, Inc. Revenue Growth Rate in Endothelin Receptor Antagonist Business (2020-2025)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies